PROTA THERAPEUTICS
Prota Therapeutics is an Australian, proprietary limited, privately-held biotech company established in 2016 to develop and commercialize novel combination probiotic allergen oral immunotherapy treatments. Prota holds an exclusive license to the patented probiotic food immunotherapy technology, developed at the MCRI. Series A funding of AUD $15m was secured from OneVentures, a leading Australian venture capital investment firm (OneVentures' Healthcare Fund III) – including $5M from the Austral... ian Commonwealth Government Biomedical Translation Fund – as well as private investment. This has enabled Prota to advance their clinical program, develop scalable cGMP product manufacturing processes, and initiate discussions with regulatory agencies in the lead up to a planned large-scale pivotal Phase 3 efficacy and safety study for the PRT100 peanut allergy treatment.
PROTA THERAPEUTICS
Social Links:
Industry:
Biotechnology Product Research Therapeutics
Founded:
2016-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.protatherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Mobile Non Scaleable Content Microsoft Exchange Online Amazon
Current Employees Featured
Founder
Investors List
OneVentures
OneVentures investment in Series A - Prota Therapeutics
Official Site Inspections
http://www.protatherapeutics.com Semrush global rank: 5.74 M Semrush visits lastest month: 1.46 K
- Host name: web2.brightspire.com.au
- IP address: 95.111.217.214
- Location: Ukraine
- Latitude: 50.4522
- Longitude: 30.5287
- Timezone: Europe/Kiev
More informations about "Prota Therapeutics"
Company Background - Prota Therapeutics
Company Background Established in 2016, Prota Therapeutics is an Australian biotech company dedicated to developing and commercializing cutting-edge oral immunotherapy treatments. …See details»
Prota Therapeutics - Crunchbase Company Profile …
Prota Therapeutics is an Australian, proprietary limited, privately-held biotech company established in 2016 to develop and commercialize novel …See details»
Prota Therapeutics 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Prota Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
PROTA THERAPEUTICS PTY LTD - The Org
View PROTA THERAPEUTICS PTY LTD's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Prota Therapeutics | SPRIM Global Investments
Prota Therapeutics is an Australian biotech company developing allergen oral immunotherapies for the treatment of food allergies.See details»
Prota Therapeutics - VentureRadar
"Prota Therapeutics is an Australian biotech company developing allergen oral immunotherapies for the treatment of food allergies. Our technology is based on two decades of research led by …See details»
Prota Therapeutics | Melbourne Startups
The company is also actively pursuing the development of treatments for other common food allergies. By collaborating with leading researchers and medical professionals, Prota …See details»
DEVELOPING A NOVEL APPROACH TO ALLERGEN …
OUR MISSION IS TO PROVIDE LONG-LASTING PEACE OF MIND TO FOOD ALLERGY SUFFERERS Prota Therapeutics, a late clinical-stage biotech company, is dedicated to advancing allergen oral …See details»
Prota Therapeutics Company Profile - Office Locations ... - Craft
Prota Therapeutics has 1 employees at their 1 location. See insights on Prota Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Prota Therapeutics US $21 Million Financing Led by SPRIM Global …
Jan 16, 2024 Financing advances development of Prota’s peanut allergy remission therapy in preparation for a Phase 3 clinical trial Prota Therapeutics Pty Ltd (Prota), an Australian …See details»
Prota Therapeutics raises $31m for peanut allergy cure
Jan 18, 2024 Prota Therapeutics raises $31.6m to advance a cure for peanut allergySee details»
Allergies biotech startup Prota Therapeutics innoculated with $32 ...
Jan 17, 2024 Melbourne biotech startup Prota Therapeutics has raised US$21 million (A$32m) ahead of a Phase 3 clinical trial for its oral therapy treatment for peanut allergy. The round, a …See details»
Board of Directors | Prota Therapeutics
Patrick Machado Independent Director and Chair 30 years’ experience in the biotech sector and a deep understanding of the scientific and regulatory processes involved in bringing new …See details»
Prota Therapeutics company information, funding & investors
Prota Therapeutics, a company developing immuno-therapy treatments for peanut allergies. Here you'll find information about their funding, investors and team.See details»
SPRIM Global Funds Prota's Promising Peanut Allergy Treatment …
Prota Therapeutics recently announced financing of $21 million in equity and debt financing. The round, led by Singapore-based SPRIM Global Investments (SGI), will help the company …See details»
Prota Therapeutics US $21 Million Financing Led by SPRIM Global …
Jan 16, 2024 The peanut allergy therapeutics market is projected to reach US$1 billion by 2030, growing at a compound annual rate of 10%, in part due to the increasing incidence of peanut …See details»
Prota Therapeutics Strengthens Board with Appointment of Global …
Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado Prota Therapeutics appoints Patrick Machado as Chair to its Board of Directors.See details»
Australia’s ProTA accelerates the development of immunotherapy …
Allergy immunotherapy company ProTA Therapeutics Pty Ltd (ProTA) will accelerate the development of a possible treatment for life-threatening peanut allergy with the appointment of …See details»
Management | Prota Therapeutics
DR MARK HASLETON Acting CEO Over 20 years of global biotech / device and pharma experience, management positions at Bristol Myers-Squibb and Teva Pharmaceuticals, and …See details»
media - Prota Therapeutics
Melbourne, Australia: Allergy immunotherapy company Prota Therapeutics Pty Ltd (Prota) is pleased to announce results from a follow up study of the probiotic and peanut immunotherapy …See details»